SPF 15 Anti-shine moisturizing

Manufacturer
Laboratoire Dr Renaud Inc.
Effective date
2011-11-29
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:30:14

Label at a glance#

ProductSPF 15 Anti-shine moisturizing
Active ingredientOCTINOXATE, OCTOCRYLENE
Label structure2 sections

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Octinoxate (Octyl Methoxycinnamate) 7.77% w/w and Octocrylene 0.10% w/w

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

WATER/EAU • BIOSACCHARIDE GUM-1 • METHYL GLUCETH-20 • GLYCERIN •VITIS VINIFERA (GRAPE) SEED OIL • DICAPRYLYL CARBONATE • METHYLMETHACRYLATE CROSSPOLYMER • SACCHARIDE ISOMERATE • CETEARYL OLIVATE • DIPROPYLENE GLYCOL • SORBITAN OLIVATE • CANDIDA BOMBICOLA/GLUCOSE/METHYL RAPESEEDATE FERMENT • SILICA • ALPHA GLUCAN OLIGOSACCHARIDE • TALC • SODIUM PALMITOYL PROLINE • AMMONIUM ACRYLOYL DIMETHYLTAURATE/VP COPOLYMER • OLEA EUROPAEA (OLIVE) LEAF EXTRACT • NYMPHEA ALBA FLOWER EXTRACT • HELIANTHUS ANNUUS (SUNFLOWER) OIL • XANTHAN GUM • KAEMPFERIA GALANGA (GALANGAL) EXTRACT • ROSMARINUS OFFICINALIS (ROSEMARY) OIL • SARCOSINE • SALVIA SOLAREA (CLARY SAGE) OIL • CITRUS AURANTIUM (ORANGE) OIL • CITRUS RETICULATA BLANCO (MANDARIN) OIL • BUTYLENE GLYCOL • GLUCAMINE • CHLORPHENESIN • CITRUS LIMON (LEMON) OIL • CITRUS AURANTIFOLIA (LIME) OIL • CYMBOPOGON SCHOENANTHUS (LEMONGRASS) OIL • PHENOXYETHANOL • ETHYLHEXYLGLYCERIN • BHT • PVP •

OTC - PURPOSE SECTION

DOSAGE & ADMINISTRATION SECTION

In the morning, first cleanse the skin thoroughly. Then apply a thin layer of your specific skin care product. End with the application of the Anti-Shine Moisturizing Lotion SPF 15. Apply prior to sun exposure.

WARNINGS SECTION

For external use only. Keep out of reach of children. Avoid direct contact with the eyes. If product gets into the eyes, rinse liberally with water. Discontinue use if skin irritation develops or increases. If irritation persists, consult a doctor.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image of tube 50 ml label


image of tube 50ml labelimage of tube 50ml label

image of carton 50ml label

image of carton 50ml labelimage of carton 50ml label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
62499-445-112019-11-13C16284748780-197449f38-b930-f6ea-e053-dbdaa90aa703Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62499-445-04SPF 15 Anti-shine moisturizing50 g in 1 TUBELOTION503
62499-445-11SPF 15 Anti-shine moisturizing1 in 1 CARTONLOTION13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62499-445SPF 15 ANTI-SHINE MOISTURIZING (OCTINOXATE AND OCTOCRYLENE) LOTION [LABORATOIRE DR RENAUD INC.]3Legacy NDC, 2 package rows20111130_fd4d2959-a8cb-4e88-9bf9-e1350d7e609b.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
OCTINOXATEACTIVE INGREDIENT4Y5P7MUD513
OCTOCRYLENEACTIVE INGREDIENT5A68WGF6WM3
OCTINOXATEACTIVE MOIETY4Y5P7MUD513
OCTOCRYLENEACTIVE MOIETY5A68WGF6WM3
.ALPHA.-GLUCAN OLIGOSACCHARIDEINACTIVE INGREDIENTS95658MI3W3
AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMERINACTIVE INGREDIENTW59H9296ZG3
BIOSACCHARIDE GUM-1INACTIVE INGREDIENTBB4PU4V09H3
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171K3
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA3
CETEARYL OLIVATEINACTIVE INGREDIENT58B69Q84JO3
CHLORPHENESININACTIVE INGREDIENTI670DAL4SZ3
CLARY SAGE OILINACTIVE INGREDIENT87L0D4U3M03
DICAPRYLYL CARBONATEINACTIVE INGREDIENT609A3V1SUA3
DIPROPYLENE GLYCOLINACTIVE INGREDIENTE107L85C403
ETHYLHEXYLGLYCERININACTIVE INGREDIENT147D247K3P3
GLUCAMINEINACTIVE INGREDIENT5QN16UUF803
GLYCERININACTIVE INGREDIENTPDC6A3C0OX3
GRAPE SEED OILINACTIVE INGREDIENT930MLC8XGG3
LEMON OILINACTIVE INGREDIENTI9GRO824LL3
LESSER GALANGAL ROOTINACTIVE INGREDIENT42LD90786Y3
LIME OILINACTIVE INGREDIENTUZH29XGA8G3
MANDARIN OILINACTIVE INGREDIENTNJO720F72R3
METHYL GLUCETH-20INACTIVE INGREDIENTJ3QD0LD11P3
METHYL METHACRYLATEINACTIVE INGREDIENT196OC776883
NYMPHAEA ALBA FLOWERINACTIVE INGREDIENT40KQ7Q535O3
OLEA EUROPAEA LEAFINACTIVE INGREDIENTMJ95C3OH473
ORANGE OILINACTIVE INGREDIENTAKN3KSD11B3
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T3
POVIDONE K30INACTIVE INGREDIENTU725QWY32X3
ROSEMARY OILINACTIVE INGREDIENT8LGU7VM3933
SACCHARIDE ISOMERATEINACTIVE INGREDIENTW8K377W98I3
SARCOSINEINACTIVE INGREDIENTZ711V88R5F3
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU43
SODIUM PALMITOYL PROLINEINACTIVE INGREDIENT64L053FRFO3
SORBITAN OLIVATEINACTIVE INGREDIENTMDL271E3GR3
SUNFLOWER OILINACTIVE INGREDIENT3W1JG795YI3
TALCINACTIVE INGREDIENT7SEV7J4R1U3
WATERINACTIVE INGREDIENT059QF0KO0R3
WEST INDIAN LEMONGRASS OILINACTIVE INGREDIENT5BIA40E9ED3
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEE3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 40 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62499-44562499-445-04, 62499-445-11

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 38 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 284 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / OPHTHALMIC12 mgExact identifier — unii candidate
75 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, DELAYED RELEASE / ORAL349 mgExact identifier — unii candidate
35 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XAEROSOL, FOAM / TOPICAL1.9 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / SUBLINGUAL32.4 mgExact identifier — unii candidate
35 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / RESPIRATORY (INHALATION)5 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XTABLET, CHEWABLE / ORAL245 mgExact identifier — unii candidate
40 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXOINTMENT / TOPICALNAExact identifier — unii candidate
75 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4PELLET / ORAL34 mgExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4POWDER / ORAL602 mgExact identifier — unii candidate
49 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXEMULSION / OPHTHALMIC3 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii candidate
75 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, FOR SUSPENSION / ORAL220 mgExact identifier — unii candidate
49 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXDROPS / ORAL300 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KTABLET, FOR SUSPENSION / ORAL0.1 mgExact identifier — unii candidate
32 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, EXTENDED RELEASE / ORAL5119 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UPOWDER, FOR SUSPENSION / ORAL735 mgExact identifier — unii candidate
35 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XTABLET / BUCCAL1 mgExact identifier — unii candidate
40 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE / ORAL322 mgExact identifier — unii candidate
35 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KCAPSULE, LIQUID FILLED / ORAL0.1 mgExact identifier — unii candidate
32 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KAEROSOL, FOAM / TOPICAL4 mgExact identifier — unii candidate
32 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XSOLUTION / ORAL300 mgExact identifier — unii candidate
40 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XSOLUTION / OPHTHALMIC42 mgExact identifier — unii candidate
40 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEETABLET, CHEWABLE, EXTENDED RELEASE / ORAL6 mgExact identifier — unii candidate
29 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XINJECTION / INTRAMUSCULAR0.59 %w/vExact identifier — unii candidate
40 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XCAPSULE, EXTENDED RELEASE / ORAL120 mgExact identifier — unii candidate
40 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, CHEWABLE / ORAL254 mgExact identifier — unii candidate
49 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KCREAM / VAGINAL0.05 %w/wExact identifier — unii candidate
32 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / BUCCAL15 mgExact identifier — unii candidate
35 equally ranked IID candidates
BUTYLENE GLYCOLBUTYLENE GLYCOL3XUS85K0RASYSTEM / TOPICAL1400 mgExact identifier — unii candidate
2 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / OPHTHALMIC6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, DELAYED RELEASE / ORAL420 mgExact identifier — unii candidate
35 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GEL / TOPICAL6 mgExact identifier — unii candidate
49 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION / INTRADERMAL1.6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / AURICULAR (OTIC)25 mgExact identifier — unii candidate
75 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, ORALLY DISINTEGRATING / ORAL80 mgExact identifier — unii candidate
35 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSPRAY / NASAL22.3 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XCAPSULE, DELAYED RELEASE / ORAL227 mgExact identifier — unii candidate
40 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, FILM COATED / ORAL1.55 mgExact identifier — unii candidate
75 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XSYSTEM / TRANSDERMAL15 mgExact identifier — unii candidate
40 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4GEL / VAGINAL8 %w/wExact identifier — unii candidate
49 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE / ORAL300 mgExact identifier — unii candidate
49 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAVENOUS15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XSOLUTION/ DROPS / OPHTHALMIC4 mgExact identifier — unii candidate
40 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXMOUTHWASH / BUCCAL100 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, CHEWABLE / ORAL202 mgExact identifier — unii candidate
35 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEETABLET, ORALLY DISINTEGRATING / ORAL0.15 mgExact identifier — unii candidate
29 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, FOR SUSPENSION / ORAL24 mgExact identifier — unii candidate
35 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOAP / TOPICAL0.76 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, CHEWABLE, EXTENDED RELEASE / ORAL2 mgExact identifier — unii candidate
49 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION/ DROPS / ORAL750 mgExact identifier — unii candidate
75 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
35 equally ranked IID candidates
LEMON OILLEMON OIL, COLD PRESSEDI9GRO824LLCAPSULE / ORAL8.5 mgExact identifier — unii candidate
4 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XCAPSULE / ORAL540 mgExact identifier — unii candidate
40 equally ranked IID candidates
ORANGE OILORANGE OIL, COLD PRESSEDAKN3KSD11BLIQUID / ORAL50 mgExact identifier — unii candidate
6 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XPOWDER, FOR SUSPENSION / ORAL257 mgExact identifier — unii candidate
40 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCREAM / TOPICAL1720 mgExact identifier — unii candidate
75 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, DELAYED RELEASE PARTICLES / ORAL170 mgExact identifier — unii candidate
49 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLOTION / TOPICAL3990 mgExact identifier — unii candidate
75 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / RECTAL32.4 mgExact identifier — unii candidate
35 equally ranked IID candidates
POVIDONE K30POVIDONE K30U725QWY32XCAPSULE, COATED, EXTENDED RELEASE / ORAL15 mgExact identifier — unii candidate
40 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2362cebc-f7d7-468f-930f-a85e96afad5dfd4d2959-a8cb-4e88-9bf9-e1350d7e609b2011-11-29WarningsExact identifier
spl id: 2362cebc-f7d7-468f-930f-a85e96afad5d
spl set id: fd4d2959-a8cb-4e88-9bf9-e1350d7e609b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.